$BOUL #Boule Diagnostics AB Boule Diagnostics - Harvesting in 2020 postponed: Q1 results due 7 May ‘20e EBIT down 33% - instruments sold down -26% y-o-y 14.3x EBIT ‘21e is 14% below historical average https://t.co/5uw3i1qqJx #equity #stocks https://t.co/HbfvJ6RZLN